Alnylam Pharmaceuticals Inc (FRA:DUL)
€ 281 +8 (+2.93%) Market Cap: 36.70 Bil Enterprise Value: 35.18 Bil PE Ratio: 85.53 PB Ratio: 38.84 GF Score: 63/100
Sorry the transcript is not found. Please try another one.